Rv3687c Anti-sigma F factor antagonist (spoIIAA-2); Anti-sigma B factor antagonist RsbV
Rv3687c (Anti-sigma F factor antagonist (spoIIAA-2); Anti-sigma B factor antagonist RsbV) is predicted to be co-regulated in modules bicluster_0104 with residual 0.59 and bicluster_0379 with residual 0.53.
This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 3,600.00 and 3,500.00 for bicluster_0104 and 8.60 and 9.10 for bicluster_0379 respectively.
These modules are enriched for following go terms: pyrimidine nucleobase biosynthetic proce..., pyrimidine nucleobase metabolic process, nucleobase biosynthetic process NAD(P)+ transhydrogenase activity, oxidoreductase activity, acting on NAD(P....
This gene is found to be for growth on cholesterol.
|Product (LegacyBRC)||Product (RefSeq)|
|ANTI-ANTI-SIGMA FACTOR RSFB [ANTI-SIGMA FACTOR ANTAGONIST] [REGULATOR OF SIGMA F B]||anti-anti-sigma factor RSFB (anti-sigma factor antagonist) (regulator of sigma F B)|
|BioCyc Gene Page||Cellular Overview Map|
Quantitative Proteomics Data
TRIP log2 fold abundance change
reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.